705 related articles for article (PubMed ID: 29128343)
1. Post-stroke depression: Mechanisms and pharmacological treatment.
Villa RF; Ferrari F; Moretti A
Pharmacol Ther; 2018 Apr; 184():131-144. PubMed ID: 29128343
[TBL] [Abstract][Full Text] [Related]
2. Post-stroke depression: mechanisms, translation and therapy.
Loubinoux I; Kronenberg G; Endres M; Schumann-Bard P; Freret T; Filipkowski RK; Kaczmarek L; Popa-Wagner A
J Cell Mol Med; 2012 Sep; 16(9):1961-9. PubMed ID: 22348642
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Legg LA; Tilney R; Hsieh CF; Wu S; Lundström E; Rudberg AS; Kutlubaev MA; Dennis M; Soleimani B; Barugh A; Hackett ML; Hankey GJ; Mead GE
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769878
[TBL] [Abstract][Full Text] [Related]
4. The psychopharmacology of brain vascular disease/poststroke depression.
Jones M; Corcoran A; Jorge RE
Handb Clin Neurol; 2019; 165():229-241. PubMed ID: 31727214
[TBL] [Abstract][Full Text] [Related]
5. In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs).
Yi J; Lu J; Yang A; Marsh EB
BMC Psychiatry; 2022 Nov; 22(1):722. PubMed ID: 36402974
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance.
Mortensen JK; Andersen G
Expert Opin Pharmacother; 2021 Jun; 22(9):1157-1166. PubMed ID: 33530765
[No Abstract] [Full Text] [Related]
7. Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.
Mortensen JK; Andersen G
Expert Opin Drug Saf; 2015 Jun; 14(6):911-9. PubMed ID: 25835753
[TBL] [Abstract][Full Text] [Related]
8. The neurobiological pathogenesis of poststroke depression.
Feng C; Fang M; Liu XY
ScientificWorldJournal; 2014; 2014():521349. PubMed ID: 24744682
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: a rat model of post-stroke depression.
Wang SH; Zhang ZJ; Guo YJ; Teng GJ; Chen BA
Psychiatry Res; 2009 Dec; 170(2-3):245-51. PubMed ID: 19896211
[TBL] [Abstract][Full Text] [Related]
10. Advances in antidepressants for treating post-stroke depression.
Paolucci S
Expert Opin Pharmacother; 2017 Jul; 18(10):1011-1017. PubMed ID: 28535081
[TBL] [Abstract][Full Text] [Related]
11. Effects of wheel-running on anxiety and depression-relevant behaviours in the MCAO mouse model of stroke: moderation of brain-derived neurotrophic factor and serotonin receptor gene expression.
Brait VH; Jackman KA; Pang TY
Behav Brain Res; 2022 Aug; 432():113983. PubMed ID: 35777551
[TBL] [Abstract][Full Text] [Related]
12. Post-stroke depression: an update.
Espárrago Llorca G; Castilla-Guerra L; Fernández Moreno MC; Ruiz Doblado S; Jiménez Hernández MD
Neurologia; 2015; 30(1):23-31. PubMed ID: 22901370
[TBL] [Abstract][Full Text] [Related]
13. Serotonin Selective Reuptake Inhibitors (SSRIs) and Stroke.
Chollet F; Rigal J; Marque P; Barbieux-Guillot M; Raposo N; Fabry V; Albucher JF; Pariente J; Loubinoux I
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):100. PubMed ID: 30353288
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of agomelatine versus SSRIs/SNRIs for post-stroke depression: a systematic review and meta-analysis of randomized controlled trials.
Chen Y; Li J; Liao M; He Y; Dang C; Yu J; Xing S; Zeng J
Int Clin Psychopharmacol; 2024 May; 39(3):163-173. PubMed ID: 37781768
[TBL] [Abstract][Full Text] [Related]
15. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression.
Bhogal SK; Teasell R; Foley N; Speechley M
J Am Geriatr Soc; 2005 Jun; 53(6):1051-7. PubMed ID: 15935033
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Citalopram in Treating Post-Stroke Depression: A Meta-Analysis.
Tan S; Huang X; Ding L; Hong H
Eur Neurol; 2015; 74(3-4):188-201. PubMed ID: 26559658
[TBL] [Abstract][Full Text] [Related]
17. A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview.
Gao Z; Wang Y; Yu H
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676679
[TBL] [Abstract][Full Text] [Related]
18. Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities.
Singh T; Goel RK
Neurochem Res; 2021 Jun; 46(6):1305-1321. PubMed ID: 33665775
[TBL] [Abstract][Full Text] [Related]
19. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke: A meta-analysis.
Zhou S; Liu S; Liu X; Zhuang W
Medicine (Baltimore); 2020 Feb; 99(6):e19062. PubMed ID: 32028426
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance and possibilities of therapy of post-stroke depression].
Trusova NA; Levin OS
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
